Catalyst Wire Dossier Catalyst Wire Dossier

3% hypertonic saline (nebulized)

sodium chloride 3% solution
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 3% hypertonic saline (nebulized), covering 2018-01-09 to 2018-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department [Phase 4]

See pricing